[1]李欣倩,姜婷婷,朱静静,等.过氧化物酶体增殖物激活受体γ与细胞自噬的关系研究进展[J].新乡医学院学报,2021,38(4):390-395.[doi:10.7683/xxyxyxb.2021.04.021]
点击复制

过氧化物酶体增殖物激活受体γ与细胞自噬的关系研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年4
页码:
390-395
栏目:
综述
出版日期:
2021-04-05

文章信息/Info

作者:
李欣倩姜婷婷朱静静闫 勇吴曙辉
(上海中医药大学附属曙光医院宝山分院耳鼻喉科,上海 200032)
关键词:
过氧化物酶体增殖物激活受体γ自噬研究进展
分类号:
R36
DOI:
10.7683/xxyxyxb.2021.04.021
文献标志码:
A
摘要:
过氧化物酶体增殖物激活受体γ(PPARγ)参与体内多种重要的生物化学反应及生物调节过程。自噬对细胞的形态、结构、功能以及代谢有着重要的意义。机体处于病理状态时,自噬被显著激活,且由多种复杂的信号通路共同调控。不同物种或同种物种不同组织中,PPARγ被激活后可通过多个途径调节自噬。本文就PPARγ与细胞自噬及二者的关系综述如下。

参考文献/References:

[1] 张双洋.PPAR-γ对大鼠肾缺血再灌注损伤后肾小管上皮细胞自噬的调控作用[D].南昌:南昌大学,2017.
[2] 袁舒平.脑心通/PPARγ信号通路抑制心肌细胞肥大与损伤[D].镇江:江苏大学,2017.
[3] ZHONG J,GONG W,CHEN J,et al.Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR signaling[J].Int Immunopharmacol,2018,59:197-208.
[4] HSIAO P J,CHIOU H Y C,JIANG H J,et al.Pioglitazone enhances cytosolic lipolysis,β-oxidation and autophagy to ameliorate hepatic steatosis[J].Scientific Reports,2017,7(1):9030.
[5] ZHONG J G,WANG Q,LU L,et al.Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ,AMPK/Akt/mTOR signaling and autophagy[J].Int Immunopharmacol,2017,42:176-184.
[6] TO K K W,WU W K K,LOONG H H F.PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy[J].Eur J Pharmacol,2018,823:19-26.
[7] 张艳.PPARγ配体罗格列酮对人肝癌细胞系HepG2自噬的影响及其机制探讨[D].武汉:华中科技大学,2011.
[8] ZHANG L,FANG Y,CHENG X,et al.TRPML1 Participates in the progression of Alzheimer′s disease by regulating the PPARγ/AMPK/mTor signalling pathway[J].Cell Physiol Biochem,2017,2446-2456.
[9] LI H,ZHANG Q,YANG X,et al.PPAR-γ agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury[J].Neurosci Lett,2017,650:89-96.
[10] JUAN J,TENG F X,XU D G,et al.Antagonizing peroxisome proliferator-activated receptor γ facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway[J].Aging Cell,2018,17(4).
[11] 金希.硒调控PPAR-γ/PI3K/Akt通路颉颃镉诱导的鸡胰腺细胞凋亡与自噬机理的研究[D].哈尔滨:东北农业大学,2019.
[12] 冯敞.PPARγ-mTORC2通路介导黄绿青霉素所致细胞自噬的作用研究[D].大连:大连医科大学,2017.
[13] ZHU Y,KAN L,QI C,et al.Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR[J].J Biol Chem,2000,275(18):13510-13516.
[14] ISSEMANN I,GREEN S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J].Nature,1990,347(6294):645-650.
[15] ROSEN E D,HSU C H,WANG X,et al.C/EBPalpha induces adipogenesis through PPARγ:a unified pathway[J].Gene Dev,2002,16(1):22-26.
[16] ROCCHI S,AUWERX J.Peroxisome proliferator-activated receptor-γ:a versatile metabolic regulator[J].Ann Med,1999,31(5):342-351.
[17] FAJAS L,FRUCHART J C,AUWERX J.PPARγ 3 mRNA:a distinct PPARγ mRNA subtype transcribed from an independent promoter[J].Febs Letters,1998,438 (1-2):55-60.
[18] TAUTENHAHN A,BRUNE B,VON KNETHNE A,et al.Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis[J].J Leukocyte Biol,2003,73(5):665-672.
[19] ZHANG Y,LI X,FANG S,et al.Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis[J].Mol Med Rep,2017,16(2):1793-1800.
[20] KLIEWER S A,SUNDSETH S S,JONES S A,et al.Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors[J].P Natl Acad Sci USA,1997,94(9):4318-4323.
[21] FORMAN B M,TONTONOZ P,CHEN J,et al.15_Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma[J].Cell,1995,83(5):803-812.
[22] BODEN G,CHEUNG P,MOZZOLI M,et al.Effect of thiazolidine-diones on glucose and fatty acid metabolism in patients with type 2 diabetes[J].Metabolism,2003,52(6):753-759.
[23] MIZUSHIMA N,YAMAMOTO A,MASTUI M,et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker[J].Mol Biol Cell,2004,15(3):1101-1111.
[24] NATH D,SHADAN S.The ubiquitin system [J].Nature,2009,458(7237):421-421.
[25] MIZUSHIMA N,KOMATSU M.Autophagy:renovation of cells and tissues[J].Cell,2011,147(4):728-741.
[26] WILLIAM A,DUNN J.Autophagy and related mechanisms of lysosome-mediated protein degradation[J].Trends Cell Biol,1994,4(4):139-143.
[27] SEGLEN P,BOHLEY P.Autophagy and other vacuolar protein degradation mechanisms[J].Experientia,1992,48(2):158-172.
[28] MEHRPOUR M,ESCLATINE A,BEAU I,et al.Overview of macroautophagy regulation in mammalian cells [J].Cell Res,2010,20(7):748-762.
[29] ZHANG Y,CHEN M L,ZHOU Y,et al.Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway[J].Mol Nutr Food Res,2015,59 (8):1443-1457.
[30] TURKMEN K.Inflammation,oxidative stress,apoptosis,and autophagy in diabetes mellitus and diabetic kidney disease:the four horsemen of the apocalypse[J].Int Urol Nephrol,2016,49(5):837-844.
[31] MATBOLI M,EISSA S,IBRAHIM D,et al.Caffeic acid attenuates diabetic kidney disease via modulation of autophagy in a high-fat diet/streptozotocin- induced diabetic rat[J].Sci Rep,2017,7(1):2263.
[32] YANG D,LIVINGSTON M,LIU Z,et al.Autophagy in diabetic kidney disease:regulation,pathological role and therapeutic potential[J].Cell Mol Life Sci,2018,75(4):669-668.
[33] LIU Y N,WANG Y X,LIU X F,et al.Citreoviridin induces ROS-dependent autophagic cell death in human liver HepG2 cells[J].Toxicon,2015,95:30-37.
[34] GANLE I G,LAM D H,WANG J,et al.ULK1 center dot ATG13 center dot FIP200 complex mediates mTOR signaling and is essential for autophagy [J].J Biol Chem,2009,284(18):297-305.
[35] LAN G,GANLEY,DU H,et al.ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy[J].J Biol Chem,2009,284(18):12297.
[36] MIZUSHIMA N,YOSHIMORI T,LEVINE B.Methods in mammalian autophagy research[J].Cell,2010,140(3):313-326.
[37] HE C,KLIONSKY D J.Regulation mechanisms and signaling pathways of autophagy[J].Annu Rev Genet,2009,43:67-93.
[38] ESKELINEN E L,SAFTIG P.Autophagy:a lysosomal degradation pathway with a central role in health and disease[J].Biochim Biophys Acta,2009,1793(4):664-673.
[39] LIANG X H,JACKSON S,SEAMAAN M,et al.Induction of autophagy and inhibition of tumorigenesis by beclin 1[J].Nature,1999,402(6762):672-676.
[40] LTAKURA E,KISHI C,INOUE K,et al.Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG [J].Mol Biol Cell,2008,19(12):5360-5372.
[41] SUN Q,FAN W,CHEN K,et al.Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase[J].P Natl A Sci India B,2009,105(49):19211-19216.
[42] MIZUSHIMA N,KUMA A,KOBAYASHI Y,et al.Mouse Apg16L,a novel WD-repeat protein,targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate[J].J Cell Sci,2003,116(9):1679-1688.
[43] KABEYA Y,MIZUSHIMA N,UENO T,et al.LC3,a mammalian homologue of yeast Apg8p,is localized in autophagosome membranes after processing[J].Embo J,2000,19 (21):5720-5728.
[44] LI X,FAN Z.The EGFR antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1α and Bcl2 and activating the beclin-1/hVps34 complex[J].Cancer Res,2010,70(14):5942-5952.
[45] MIZUSHIMA N,KUMA A.Autophagosomes in GFP-LC3 transgenic mice[J].Mol Biol Rep,2008,445(445):119.
[46] BJORKOY G,LAMARK T,BRECH A,et al.p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death[J].J Cell Biol,2005,171(4):603-614.
[47] HAY N,SONENBERG N.Upstream and downstream of mTOR[J].Genes Dev,2004,18(16):1926-1945.
[48] LEE J M,WAGNER M,XIAO R,et al.Nutrient-sensing nuclear receptors coordinate autophagy[J].Nature,2014,516(7529):112-115.
[49] JOUNGMO K,MONDIRA K,VIOLLET B,et al.AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J].Nat Cell Biol,2011,13(2):132-141.
[50] ASUKA S,MICHIO S,DAIJU F,et al.Telmisartan ameliorates insulin sensitivity by activating the AMPK /SIRT 1 pathway in skeletal muscle of obese db/db mice[J].Cardiovasc Diabetol,20l2,11:139.
[51] WANG Y,LI X,GUO Y,et al.Alpha-lipoic acid increases energy expenditure by enhancing AMPK-PGC-1α signalling in the skeletal muscle of aged mice[J].Metabolism,2010,59(7):967.
[52] YOUNG H C,JIN K B,CHAE H S,et al.α-mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARγ pathway in high fat diet induced obese mice[J].J Agr Food Chem,2015,63(8),399-406.
[53] HAY N,SONENBERG N.Upstream and downstream of mTOR[J].Genes Dev,2004,18(16):1926-1945.
[54] NAZIM U M,MOON J H,LEE J H,et al.Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis[J].Oncotarget,2016,7(17):23468-23481.
[55] SHIMIZU S,KANASEKI T,MIZUSHIMA N,et al.Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes[J].Nat Cell Biol,2004,6(12):1221-1228.
[56] SEARGENT J M,YATES E A,GILL J H.GW9662,a potent antagonist of PPARγ,inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone,independently of PPARγ activation[J].Br J Pharmacol,2004,143(8):933-937.
[57] FUJISAWA T,SUGIYAMA M,TOMIMOYO A,et al.Inhibition of peroxisome proliferator-activated receptor γ promotes tumorigenesis through activation of the β-Catenin/T cell factor (TCF) pathway in the mouse intestine[J].J Pharmacol Sci,2008,108(4):535-544.
[58] MASUDA T.Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma[J].Clin Cancer Res,2005,11(11):4012-4021.
[59] LEA M A,SURA M,DESBORDES C .Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) γ agonists and antagonists [J].Anticancer Res,2004,24(5A):2765-2771.
[60] KATHERINE L S,KOICHIRO W,HIROKAZU T,et al.Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells[J].Cancer Res,2005,65(6):2251-2259.

更新日期/Last Update: 2021-04-05